Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area - a population-based registry study

• Published in: Infectious diseases (London, England) England), 2021-10, Vol.53 (10), p.789-799
• Main Authors: Forsblom, Erik, Silén, Suvi, Kortela, Elisa, Ahava, Maarit, Kreivi, Hanna-Riikka, Holmberg, Ville, Järvinen, Asko, Hästbacka, Johanna, Kivivuori, Sanna-Maria, Meretoja, Atte
• Format: Article
• Language: English
• Subjects: Covid-19; male sex; mortality
• ISSN: 2374-4235; 2374-4243
• DOI: 10.1080/23744235.2021.1936157

Men reportedly suffer from a more severe disease and higher mortality during the global SARS-CoV-2 (Covid-19) pandemic. We analysed sex differences in a low epidemic area with low overall mortality in Covid-19 in a population based setting with patients treated in specialized healthcare. We entered all hospitalized laboratory-confirmed Covid-19 cases of all specialized healthcare hospitals of the Capital Province of Finland, into a population-based quality registry and described demographics, severity and case-fatality by sex of the first Covid-19 wave February-June 2020. Altogether 5471 patients (49% male) were identified. Patients hospitalized in the specialist healthcare (N = 585, 54% male, OR 1.25; 95% CI 1.05-1.48) were of the same age. Men had less asthma and thyroid insufficiency and more coronary artery disease compared to women. Mean time from symptom onset to diagnosis was at least one day longer for men (p=.005). Men required intensive care unit (ICU) more often (27% vs. 17%) with longer lengths-of-stays at ICU. Male sex associated with significantly higher case-fatality at 90-days (15% vs. 8%) and all excess male deaths occurring after three weeks from onset. Men with fatal outcomes had delays in both Covid-19 testing and hospital admission after a positive test. The delays in patients with the most severe and fatal outcomes differed markedly by sex. In multivariable analysis, male sex associated independently with case-fatality (OR 2.37; 95% CI 1.22-4.59). Male sex associated with higher disease severity and case-fatality. Late presentation of male fatal cases could represent different treatment-seeking behaviour or disease progression by sex.